IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $657,260 | +85.1% | 16,019 | +79.7% | 0.10% | +56.5% |
Q2 2021 | $355,000 | -85.3% | 8,912 | -79.2% | 0.06% | -80.3% |
Q4 2020 | $2,417,000 | +695.1% | 42,747 | +568.1% | 0.32% | +707.7% |
Q3 2020 | $304,000 | -77.3% | 6,398 | -71.9% | 0.04% | -77.3% |
Q2 2020 | $1,342,000 | -19.5% | 22,765 | -35.4% | 0.17% | -22.2% |
Q1 2020 | $1,667,000 | +149.6% | 35,254 | +218.9% | 0.22% | +99.1% |
Q4 2019 | $668,000 | – | 11,055 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |